Literature DB >> 20097194

A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.

Yoriko Miyashita1, Taiji Furukawa, Etsuko Kamegaya, Mitsunobu Yoshii, Toshihide Nukada.   

Abstract

Amlodipine, a dihydropyridine derivative, has been shown to block not only L-type but also N-type Ca(2+) channels. Aiming to understand the mechanism underlying such a selective blockade by amlodipine, the interaction of amlodipine with N-type channels was investigated using the Xenopus oocyte expression system together with the two-microelectrode voltage-clamp technique and the binding assay for [(3)H]amlodipine. When expressed as the alpha(1B)alpha(2/)delta(1)beta(1a) combination, the N-type channel formed a high affinity binding site for [(3)H]amlodipine (K(d), 3.08nM) and was profoundly blocked by amlodipine (IC(50), 2.7 microM at -60mV). By contrast, R-type (alpha(1E)alpha(2/)delta(1)beta(1a)) channels did not possess a high affinity binding site for [(3)H]amlodipine and their channel activities were not influenced by amlodipine. In comparison of amino acid sequences in the transmembrane regions IIIS5, IIIS6 and IVS6 of the alpha(1) subunit, which are involved in dihydropyridine binding in L-type channels, the two amino acid residues Lys(1287) (corresponding to Met(1295) in alpha1B) and Phe(1699) (corresponding to Leu(1697) in alpha(1B)) were unique in alpha(1E). An amino acid substitution of Lys1287Met in IIIS5 of alpha(1E) conferred a high affinity binding site for amlodipine (K(d), 13.1nM) and a sensitivity to amlodipine (IC(50), 11.3 microM). In N-type channel, reversely, an amino acid substitution of Met1295Lys in IIIS5 of alpha(1B) deprived a high affinity binding site for amlodipine and reduced the channel blockade by amlodipine (IC(50), 29.6 microM). The results indicate that Met(1295) in the region IIIS5 of alpha(1B) is critical for amlodipine to efficiently bind and block the N-type Ca(2+) channel. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097194     DOI: 10.1016/j.ejphar.2010.01.006

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.

Authors:  Min Lin; Oluyemi Aladejebi; Gregory H Hockerman
Journal:  Eur J Pharmacol       Date:  2011-09-02       Impact factor: 4.432

2.  Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.

Authors:  Murad Abusukhun; Martin S Winkler; Stefan Pöhlmann; Onnen Moerer; Konrad Meissner; Björn Tampe; Heike Hofmann-Winkler; Michael Bauer; Markus H Gräler; Ralf A Claus
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.